![George F. Schreiner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George F. Schreiner
Directeur/Membre du Conseil chez
Epirium Bio, Inc.
Profil
George F.
Schreiner is currently the Chief Scientific Officer & Director at Epirium Bio, Inc. He previously held positions as the Chief Executive Officer at Raven Biotechnologies, Inc. from 2006 to 2008, Director at Johnson & Johnson in 2006, Director at Metabasis Therapeutics, Inc. from 2007 to 2010, and Chief Scientific Officer at Scios, Inc. from 1997 to 2006.
He also served as the VP-Medical Science & Preclinical Research at CV Therapeutics, Inc. from 1993 to 1997.
Dr. Schreiner obtained his undergraduate and doctorate degrees from Harvard University.
Postes actifs de George F. Schreiner
| Sociétés | Poste | Début |
|---|---|---|
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Directeur/Membre du Conseil | - |
Anciens postes connus de George F. Schreiner
| Sociétés | Poste | Fin |
|---|---|---|
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Directeur/Membre du Conseil | 28/01/2010 |
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops antibody therapeutics | President | 01/07/2008 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Directeur Technique/Scientifique/R&D | 01/05/2006 |
| JOHNSON & JOHNSON | Directeur/Membre du Conseil | 01/05/2006 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Directeur Technique/Scientifique/R&D | 01/01/1997 |
Formation de George F. Schreiner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops antibody therapeutics | Commercial Services |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
